Codexis Inc. (CDXS)

Codexis, Inc. (NASDAQ:CDXS) Receives $6.80 Average Target Price from Analysts - MarketBeat

MarketBeat

Codexis Inc. (CDXS) presents a great opportunity, but the stock is slightly overvalued – US Post News - US Post News

US Post News

Codexis achieves RNA oligonucleotide synthesis breakthrough By Investing.com - Investing.com Nigeria

Investing.com Nigeria

Codexis achieves RNA oligonucleotide synthesis breakthrough By Investing.com - Investing.com

Investing.com

Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting - GlobeNewswire

GlobeNewswire

Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting - Yahoo Finance

Yahoo Finance

Codexis (NASDAQ:CDXS) Stock Price Crosses Above Two Hundred Day Moving Average of $2.83 - MarketBeat

MarketBeat

Codexis (CDXS) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Lifestyle UK

Yahoo Lifestyle UK

Codexis (NASDAQ:CDXS) Share Price Crosses Above Two Hundred Day Moving Average of $2.83 - Defense World

Defense World

Codexis (CDXS) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Singapore News

Yahoo Singapore News

Codexis (NASDAQ:CDXS) Receives Buy Rating from Benchmark - Defense World

Defense World

Institutional investors are Codexis, Inc.'s (NASDAQ:CDXS) biggest bettors and were rewarded after last week's US$61m market cap gain - Simply Wall St

Simply Wall St

Codexis (NASDAQ:CDXS) Given "Buy" Rating at Benchmark - MarketBeat

MarketBeat

After Plunging 39.6% in 4 Weeks, Here's Why the Trend Might Reverse for Codexis (CDXS) - Yahoo News UK

Yahoo News UK

Codexis Reports First Quarter 2024 Financial Results - GlobeNewswire

GlobeNewswire

Codexis Reports First Quarter 2024 Financial Results | News | bakersfield.com - The Bakersfield Californian

The Bakersfield Californian

Codexis: Q1 Earnings Snapshot - Houston Chronicle

Houston Chronicle

Federated Hermes Inc. Sells 57601 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World

Defense World

Latest Innovations of Caprylic Acid Market | TerraVia Holdings, Inc., Codexis - Amoré

Amoré

Codexis to Report First Quarter 2024 Financial Results on May 2 - GlobeNewswire

GlobeNewswire

Codexis to Report First Quarter 2024 Financial Results on May 2 - GlobeNewswire

GlobeNewswire

Codexis to Report First Quarter 2024 Financial Results on May 2

GlobeNewswire Inc.

Further weakness as Codexis (NASDAQ:CDXS) drops 11% this week, taking three-year losses to 88% - Simply Wall St

Simply Wall St

Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board

GlobeNewswire Inc.

Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board - ForexTV.com

ForexTV.com

Codexis, Inc. (NASDAQ:CDXS) Q4 2023 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

Codexis (CDXS) Tops Q4 Earnings and Revenue Estimates

Zacks Investment Research

Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

GlobeNewswire Inc.

Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results - Yahoo Finance

Yahoo Finance

Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Codexis Shares Up 31% on Roche Licensing Agreement - Morningstar

Morningstar

Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche

GlobeNewswire Inc.

Codexis to Participate in TD Cowen 44th Annual Health Care Conference

GlobeNewswire Inc.

Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche - GlobeNewswire

GlobeNewswire

Can Low Occupancy Rate Affect Select Medical (SEM) Q4 Earnings?

Zacks Investment Research

Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board

GlobeNewswire Inc.

Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board - GlobeNewswire

GlobeNewswire

ANSYS (ANSS) to Report Q4 Earnings: Here's What to Expect

Zacks Investment Research

WIX Set to Report Q4 Earnings: Here's What You Should Know

Zacks Investment Research

Higher Visits to Soften Cost Blow for Teladoc (TDOC) Q4 Earnings

Zacks Investment Research

Can Low Patient Days Affect Community Health (CYH) Q4 Earnings?

Zacks Investment Research

Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28

GlobeNewswire Inc.

Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28 - Yahoo Finance

Yahoo Finance

Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones

GlobeNewswire Inc.

Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash ... - Yahoo Finance

Yahoo Finance

seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting

GlobeNewswire Inc.

seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting - GlobeNewswire

GlobeNewswire

Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108

GlobeNewswire Inc.

Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108 - Yahoo Finance

Yahoo Finance

Codexis, Inc.'s (NASDAQ:CDXS) Shares Leap 56% Yet They're Still Not Telling The Full Story - Simply Wall St

Simply Wall St